CureVac
Giusi Minniti is a highly skilled scientist with extensive experience in microbiology and enzyme production. Currently serving as a Scientist in Downstream Process Development at CureVac since September 2022, Giusi previously contributed to the production development of microbial proteases at Sacco srl from February 2019 to July 2022. Academic background includes a Doctor of Philosophy in Microbiology from NMBU - Norwegian University of Life Sciences, complemented by roles as a Doctoral Researcher focusing on microbial community analysis and as a Research Associate in various prestigious institutions, including the University of the Sunshine Coast and NTNU. Giusi's expertise encompasses genetic optimization, microbial analysis, protein expression and purification, and enzyme production processes, supported by a strong foundation in marine biology and ecology.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.